[1]
|
Kiss, E., Kranzlin, B., Wagenblaβ, K., Bonrouhi, M., Thiery, J., Grone E., Nordstrom, V., Teupser, D., Gretz, N., Malle, E. and Grone, H.J. (2013) Lipid Droplet Accumulation Is Associated with an Increase in Hyperglycemia-Induced Renal Damage: Prevention by Liver X Receptors. The American Journal of Pathology, 182, 727-741.
http://dx.doi.org/10.1016/j.ajpath.2012.11.033
|
[2]
|
Trevisan, R., Dodesini, A.R. and Lepore, G. (2003) Lipids and Renal Disease. Journal of the American Society of Nephrology, 17, S145-S147. http://dx.doi.org/10.1681/ASN.2005121320
|
[3]
|
Hattori, M., Chikamoto, H., Akioka, Y., Nakakura, H., Ogino, D., Matsunaga, A., Fukazawa, A., Miyakawa, S., Khono, M., Kawaguchi, H. and Ito, K. (2003) A Combined Low-Density Lipoprotein Apheresis and Prednisone Therapy for Steroid-Resistant Primary Focal Segmental Glomerulosclerosis in Children. American Journal of Kidney Diseases, 42, 1121-1130. http://dx.doi.org/10.1053/j.ajkd.2003.08.012
|
[4]
|
Ito, S., Machida, H., Inaba, A., Harada, T., Okuyama, K., Nakamura, T., Aihara, Y. and Yokota, S. (2007) Amelioration of Steroids and Cyclosporine-Resistant Nephrotic Syndrome by Pravastatin. Pediatric Nephrology, 22, 603-606.
http://dx.doi.org/10.1007/s00467-006-0371-4
|
[5]
|
Prescott Jr., W.A., Streetman, D.A. and Streetman, D.S. (2004) The Potential Role of HMG-CoA Reductase Inhibitors in Pediatric Nephrotic Syndrome. Annals of Pharmacotherapy, 38, 2105-2114. http://dx.doi.org/10.1345/aph.1D587
|
[6]
|
Sanjad, S.A., Al-Abbad, A. and Al-Shorafa S. (1997) Management of Hyperlipidemia in Children with Refractory Nephrotic Syndrome: The Effect of Statin Therapy. The Journal of Pediatrics, 130, 470-474.
http://dx.doi.org/10.1016/S0022-3476(97)70213-0
|
[7]
|
Jiang, T., Wang, Z., Proctor, G., Moskowitz, S., Liebman, S.E., Rogers, T., Lucia, M.S., Li J. and Levi, M. (2005) Diet-Induced Obesity in C57BL/6J Mice Causes Increased Renal Lipid Accumulation and Glomerulosclerosis via a Sterol Regulatory Element-Binding Protein-1c-Dependent Pathway. The Journal of Biological Chemistry, 280, 32317-32325. http://dx.doi.org/10.1074/jbc.M500801200
|
[8]
|
Gotoh, K., Masaki, T., Chiba, S., Ando, H., Fujiwara, K., Shimasaki, T., Tawara, Y., Toyooka, I., Shiraishi, K., Mitsutomi, K., Anai, M., Itateyama, E., Hiraoka, J., Aoki, K., Fukunaga, N., Nawata, T. and Kakuma, T. (2013) Effects of Hydrophilic Statins on Renal Tubular Lipid Accumulation in Diet-Induced Obese Mice. Obesity Research & Clinical Practice, 7, e342-e352. http://dx.doi.org/10.1016/j.orcp.2013.04.001
|
[9]
|
Eller, P., Eller, K., Wolf, A.M., Reinstadler, S.J., Tagwerker, A., Patsch, J.R., Mayer, G. and Rosenkranz, A.R. (2010) Atorvastatin Attenuates Murine Anti-Glomerular Basement Membrane Glomerulonephritis. Kidney International, 77, 428-435. http://dx.doi.org/10.1038/ki.2009.478
|
[10]
|
Fujita, E., Shimizu, A., Masuda, Y., Kuwahara, N., Arai, T., Nagasaka, S., Aki, K., Mii, A., Natori, Y., Iino, Y., Katayama, Y. and Fukuda, Y. (2010) Statin Attenuates Experimental Anti-Glomerular Basement Membrane Glomerulonephritis Together with the Augmentation of Alternatively Activated Macrophages. The American Journal of Pathology, 177, 1143-1154. http://dx.doi.org/10.2353/ajpath.2010.090608
|
[11]
|
Bussolati, B., Deregibus, M.C., Fonsato, V., Doublier, S., Spatola, T., Procida, S., Di Carlo, F. and Camussi, G. (2005) Statins Prevent Oxidized LDL-Induced Injury of Glomerular Podocytes by Activating the Phosphatidylinositol 3-Kinase/AKT-Signaling Pathway. Journal of the American Society of Nephrology, 16, 1936-1947.
http://dx.doi.org/10.1681/ASN.2004080629
|
[12]
|
Chu, G., Jia, R. and Yang, D. (2006) Fluvastatin Prevents Oxidized Low-Density Lipoprotein-Induced Injury of Renal Tubular Epithelial Cells by Inhibiting the Phosphatidylinositol 3-Kinase/Akt-Signaling Pathway. Journal of Nephrology, 19, 286-295.
|
[13]
|
Steffens, S. and Mach, F. (2006) Drug Insight: Immunomodulatory Effects of Statins—Potential Benefits for Renal Patients? Nature Clinical Practice Nephrology, 2, 378-387. http://dx.doi.org/10.1038/ncpneph0217
|
[14]
|
Stein, E.A. (2007) Statins and Children: Whom Do We Treat and When? Circulation, 116, 594-595.
http://dx.doi.org/10.1161/CIRCULATIONAHA.107.717777
|
[15]
|
Vuorio, A., Kuoppala, J., Kovanen, P.T., Humphries, S.E., Strandberg, T., Tonstad, S. and Gylling, H. (2010) Statins for Children with Familial Hypercholesterolemia. Cochrane Database of Systematic Reviews, 7, CD006401.
|
[16]
|
Prescott Jr., W.A., Streetman, D.A. and Streetman, D.S. (2004) The Potential Role of HMG-CoA Reductase Inhibitors in Pediatric Nephrotic Syndrome. Annals of Pharmacotherapy, 38, 2105-2114. http://dx.doi.org/10.1345/aph.1D587
|